Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration for Dapagliflozin ...

Kraft Heinz has proposed to carve out business related to ketchup, tomato sauce, mayonnaise, before the closing of the transaction. Post announcement, shares of Zydus Wellness closed 4.29% lower at Rs ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Dapagliflozin Tablets, 5 mg and 10 mg (USRLD: Farxiga Tablets, 5 mg and 10 mg).

Zydus Lifesciences Ltd has received final USFDA approval for its generic dapagliflozin tablets, used to manage blood sugar in type 2 diabetes patients. The approval covers 5 mg and 10 mg strengths, ...

Shares of Zydus Wellness surged 12.31% to Rs 498.65, extending gains to 17.03% over the three trading sessions.

Zydus Lifesciences has received US FDA approval for its generic version of the diabetes drug dapagliflozin, boosting its ...

Dapagliflozin tablets for diabetic patients have recorded annual sales of about $10.2 billion in the US for the 12 months ...

Shares of Zydus Lifesciences Ltd rose 3 per cent in Friday’s trade after the company announced an exclusive licencing and supply agreement with Netherlands-based Synthon BV for the US market. Zydus ...

India’s Zydus Lifesciences is in the FDA’s crosshairs once again, this time for a trio of unnamed violations at an injectables facility. Following an FDA inspection that wrapped up this week, Zydus, ...

ETHealthworld.com brings latest sharvil patel news, views and updates from all top sources for the Indian Health industry.

Zydus Lifesciences faces short-term revenue challenges but has strong long-term growth drivers in innovative medicines and ...